Nektar Therapeutics (NKTR) EBITDA Margin Growth (5y) (2015 - 2026)
Nektar Therapeutics (NKTR) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Nektar Therapeutics |
1.51 Bn |
939.55 Mn |
3.16 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
16,392.00 |
| Dec 31, 2025 |
82,938.00 |
| Sep 30, 2025 |
7,449.00 |
| Jun 30, 2025 |
-22,444.00 |
| Mar 31, 2025 |
-20,088.00 |
| Dec 31, 2024 |
37,296.00 |
| Sep 30, 2024 |
19,557.00 |
| Jun 30, 2024 |
23,983.00 |
| Mar 31, 2024 |
23,487.00 |
| Dec 31, 2023 |
86,265.00 |
| Sep 30, 2023 |
16,947.00 |
| Jun 30, 2023 |
-34,265.00 |
| Mar 31, 2023 |
-40,069.00 |
| Dec 31, 2022 |
-21,307.00 |
| Jun 30, 2022 |
-59,817.00 |
| Mar 31, 2022 |
-15,359.00 |
| Dec 31, 2021 |
-21,667.00 |
| Sep 30, 2021 |
-36,528.00 |
| Jun 30, 2021 |
-32,709.00 |
| Mar 31, 2021 |
-50,740.00 |
